Blair Greenwood
Internal Medicine · Mayflower, ARNPI 1932137148
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 448 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 48 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,645, 2.6 times the $628 reported in 2019. Among internal medicine clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 448 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$901
- Pfizer$897
- Amgen$489
- Lilly USA, LLC$425
- GSK$297
- plus $3K from 42 others
What the payments were for
- Food & beverage$7,455100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,455 in reported general payments places this provider in the 95th percentile of 614 internal medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 182 | $196,175 |
| OzempicSemaglutide | 188 | $189,159 |
| EliquisApixaban | 150 | $104,983 |
| FarxigaDapagliflozin Propanediol | 76 | $61,487 |
| JardianceEmpagliflozin | 77 | $52,765 |
| JanuviaSitagliptin Phosphate | 58 | $39,170 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 50 | $37,357 |
| Nurtec OdtRimegepant Sulfate | 17 | $34,173 |
| VraylarCariprazine Hcl | 22 | $33,572 |
| CreonLipase/Protease/Amylase | 19 | $33,502 |
| Emgality PenGalcanezumab-Gnlm | 28 | $23,577 |
| UbrelvyUbrogepant | 19 | $18,728 |
| Tresiba Flextouch U-100Insulin Degludec | 30 | $18,455 |
| XareltoRivaroxaban | 33 | $18,087 |
| LinzessLinaclotide | 26 | $14,959 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $425 | $196,175182 claims |
| Novo NordiskOzempic | $173 | $189,159188 claims |
| PfizerEliquis, Nurtec Odt, Premarin | $897 | $144,468180 claims |
| AbbVieVraylar, Creon, Ubrelvy, Linzess | $1,294 | $100,76186 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $901 | $79,005111 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Stiolto Respimat | $164 | $70,357115 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta, Breo Ellipta | $297 | $65,762113 claims |
| MerckJanuvia, Belsomra | $159 | $46,80074 claims |
| Johnson & JohnsonXarelto | $77 | $18,08733 claims |
| Astellas Pharma US IncMyrbetriq | $252 | $14,23731 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 614 internal medicine providers in Arkansas.
Other internal medicine in Mayflower
- David PyleJonesboro$93K
- Aaron StrobelLittle Rock$32K
- Stuart BensonRogers$24K
- Purnima SarkarEarle$21K
- John NorwoodJonesboro$21K
- Ahmed AliConway$18K
- Jeremy DavisLittle Rock$17K
- Tyree SealsFort Smith$14K
- Atif KhanBatesville$14K
- Ritesh RampureLittle Rock$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.